Endometriosis
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Endometriosis
- Therapeutic area
- Reproductive Health
- endometriosis
- endometriosis
- endometriosis (disease)
- All therapeutic areas
- Reproductive Health
- Severity
- Moderate
- MONDO ID
- MONDO:0005133
- Parent condition
- MONDO:0000931
Related records
Broader conditions (7)
- Disease
- Disease by body system or component
- Endometrial disorder
- Female reproductive system disorder
- Human disease
- Reproductive system disorder
- Uterine disorder
Narrower conditions (7)
- Cervix endometriosis
- Endometriosis in cutaneous scar
- Endometriosis of intestine
- Endometriosis of pelvic peritoneum
- Endometriosis of rectovaginal septum and vagina
- Fallopian tube endometriosis
- Ovarian endometriosis
Trials (867)
- 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
- " Development of Primary Cultures of Diaphragmatic Myoblasts for Basic Research Purposes "
- A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
- A Clinical Study of KLH-2109 in Patients With Endometriosis
- A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
- A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
- A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
- A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain
- A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
- A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laparoscopy to Detect Endometriosis
- A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
- A Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic and Chronic Belly Pain
- A Liquid Biopsy Diagnostic Techniques for Endometriosis
- A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
- A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398
- A Multi-omics Study of Adenomyosis
- A Multicenter, Observational Clinical Study of Dydrogesterone
- A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
- A New Algorithm to Predict Ovarian Age
- a Novel Surgical Approach for Endometriosis Surgery
Approved drugs (5)
- Danazol
- Elagolix sodium
- Medroxyprogesterone acetate
- Nafarelin acetate
- Norethindrone acetate
Drugs in development (58)
- Afatinib Phase 1
- Alcohol Early phase 1
- Anakinra Early phase 1
- Anastrozole Phase 2
- Asoprisnil Phase 2
- Atosiban Phase 2
- Axitinib Phase 1
- Bentamapimod Phase 2
- Bevacizumab Phase 1
- BX 471 Phase 2
- Cabergoline Phase 2
- Cannabidiol Phase 2
- Cetrorelix Phase 2
- Cyproterone acetate Phase 3
- Degarelix Phase 3
- Dienogest Phase 3
- Elagolix Phase 3
- Eliapixant Phase 2
- Epigalocatechin gallate Phase 2
- Estradiol Phase 3
Other linked drugs (10)
- Desogestrel
- Dichloroacetic acid
- Drospirenone
- Dydrogesterone
- Gonadorelin acetate
- Histrelin
- Lactulose
- Mannitol
- Naproxen
- Pravastatin